ShRNA-mediated FBXO16 stable knockdown promoted ovarian cancer cell proliferation, clonogenic survival, and cell invasion (Fig. 2C–E, Supplementary Fig. 1B, C). This evidence concerns the gene FBXO16 and ovarian carcinoma.